EVOLUS, INC. Number of Reporting Units
EVOLUS, INC. (EOLS) reported Number of Reporting Units of 1 reportingUnit for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:NumberOfReportingUnits · last filed 2026-08-05
- EVOLUS, INC. number of reporting units for the quarter ending 2024-03-31 was 1.00 reporting_unit, a 0.00% change year-over-year.
- EVOLUS, INC. number of reporting units for the quarter ending 2023-03-31 was 1.00 reporting_unit, a 0.00% change year-over-year.
- EVOLUS, INC. number of reporting units for the quarter ending 2022-03-31 was 1.00 reporting_unit.
- EVOLUS, INC. number of reporting units for fiscal 2024 was 1.00 reporting_unit, a 0.00% change from fiscal 2023.
- EVOLUS, INC. number of reporting units for fiscal 2023 was 1.00 reporting_unit, a 0.00% change from fiscal 2022.
- EVOLUS, INC. number of reporting units for fiscal 2022 was 1.00 reporting_unit, a 0.00% change from fiscal 2021.
- EVOLUS, INC. number of reporting units for fiscal 2021 was 1.00 reporting_unit.
reporting_unit
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2024-12-31 | 1.00 reporting_unit 10-K · filed 2025-03-04 | |||
| 2024-09-30 | 1.00 reporting_unit 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | 1.00 reporting_unit 10-Q · filed 2024-07-31 | |||
| 2024-03-31 | 1.00 reporting_unit 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | 1.00 reporting_unit 10-K · filed 2024-03-07 | |||
| 2023-09-30 | 1.00 reporting_unit 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | 1.00 reporting_unit 10-Q · filed 2023-08-02 | |||
| 2023-03-31 | 1.00 reporting_unit 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | 1.00 reporting_unit 10-K · filed 2023-03-08 | |||
| 2022-09-30 | 1.00 reporting_unit 10-Q · filed 2022-11-08 | |||
| 2022-06-30 | 1.00 reporting_unit 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | 1.00 reporting_unit 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 1.00 reporting_unit 10-K · filed 2022-03-03 | |||
| 2021-09-30 | 1.00 reporting_unit 10-Q · filed 2021-11-02 |
unit
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2021-06-30 | 1.00 unit 10-Q · filed 2021-08-04 | |||
| 2021-03-31 | 1.00 unit 10-Q · filed 2021-05-12 | |||
| 2020-12-31 | 1.00 unit 10-K · filed 2021-03-25 | |||
| 2020-09-30 | 1.00 unit 10-Q · filed 2020-10-29 | |||
| 2020-06-30 | 1.00 unit 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | 1.00 unit 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | 1.00 unit 10-K · filed 2020-02-25 | |||
| 2019-09-30 | 1.00 unit 10-Q · filed 2019-11-04 | |||
| 2019-06-30 | 1.00 unit 10-Q · filed 2019-08-12 | |||
| 2019-03-31 | 1.00 unit 10-Q · filed 2019-05-01 | |||
| 2018-12-31 | 1.00 unit 10-K · filed 2019-03-20 | |||
| 2018-09-30 | 1.00 unit 10-Q · filed 2018-11-05 | |||
| 2018-06-30 | 1.00 unit 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | 1.00 unit 10-Q · filed 2018-05-10 |
reportingUnit
| Period end | Number of Reporting Units 3 month | Number of Reporting Units 6 month | Number of Reporting Units 9 month | Number of Reporting Units 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 reportingUnit 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | 1.00 reportingUnit 10-Q · filed 2026-05-04 | |||
| 2025-12-31 | 1.00 reportingUnit 10-K · filed 2026-03-03 | |||
| 2025-09-30 | 1.00 reportingUnit 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | 1.00 reportingUnit 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | 1.00 reportingUnit 10-Q · filed 2025-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |